SCHEMBL24916381

SCHEMBL24916381

C/N=N\c1ccccc1NC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.40
SIGMAR1 Q99720 4/20 0.34
GRIN2D O15399 2/20 0.34
GRIN3B O60391 2/20 0.34
GRIN1 Q05586 2/20 0.34
GRIN2A Q12879 2/20 0.34
GRIN2B Q13224 2/20 0.34
GRIN2C Q14957 2/20 0.34
GRIN3A Q8TCU5 2/20 0.34
ATM Q13315 1/20 0.33
MAPT P10636 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
MEN1 O00255 1/20 0.30
PABPC1 P11940 1/20 0.30
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30
KMT2A Q03164 1/20 0.30
EBP Q15125 1/20 0.30
TMEM97 Q5BJF2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13283105 0.78 KDM4E (0.41) IDO1SIGMAR1GRIN2DGRIN3BGRIN1
SCHEMBL13952007 0.77 TDP1 (0.36) IDO1SIGMAR1GRIN2DGRIN3BGRIN1
SCHEMBL683597 0.77 IDO1 (0.41) IDO1SIGMAR1GRIN2DGRIN3BGRIN1
SCHEMBL25642562 0.77 IDO1 (0.41) IDO1SIGMAR1GRIN2DGRIN3BGRIN1
SCHEMBL29881429 0.77 IDO1 (0.52) IDO1ATMMAPTNPSR1
SCHEMBL6251669 0.77 IDO1 (0.52) IDO1ATMMAPTNPSR1
SCHEMBL4465102 0.74 NPC1 (0.41) MAPTMEN1TSHRKMT2A
SCHEMBL24141256 0.69 IDO1 (0.45) IDO1ATMMAPTNPSR1MEN1
SCHEMBL5163824 0.69 MAPT (0.50) IDO1MAPTTSHR
SCHEMBL24916459 0.68 IDO1 (0.38) IDO1ATMMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026056-A1 ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF Lakewood Amedex, Inc. 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026056-A1 ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF CAT, MPO, NISCH IDO1 2936/4885SIGMAR1 1211/4885GRIN2D 4281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.